297 related articles for article (PubMed ID: 31295734)
1. Peptide-based targeted polymeric nanoparticles for siRNA delivery.
Hussein WM; Cheong YS; Liu C; Liu G; Begum AA; Attallah MA; Moyle PM; Torchilin VP; Smith R; Toth I
Nanotechnology; 2019 Oct; 30(41):415604. PubMed ID: 31295734
[TBL] [Abstract][Full Text] [Related]
2. Gastrin-releasing peptide receptor-targeted hybrid peptide/phospholipid pDNA/siRNA delivery systems.
Begum AA; Toth I; Moyle PM
Nanomedicine (Lond); 2019 May; 14(9):1153-1171. PubMed ID: 31050581
[No Abstract] [Full Text] [Related]
3. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells.
Wan Y; Dai W; Nevagi RJ; Toth I; Moyle PM
Acta Biomater; 2017 Sep; 59():257-268. PubMed ID: 28655658
[TBL] [Abstract][Full Text] [Related]
5. Enhanced transfection efficiency and reduced cytotoxicity of novel lipid-polymer hybrid nanoplexes.
Jain S; Kumar S; Agrawal AK; Thanki K; Banerjee UC
Mol Pharm; 2013 Jun; 10(6):2416-25. PubMed ID: 23597269
[TBL] [Abstract][Full Text] [Related]
6. Cationic amphiphilic macromolecule (CAM)-lipid complexes for efficient siRNA gene silencing.
Gu L; Nusblat LM; Tishbi N; Noble SC; Pinson CM; Mintzer E; Roth CM; Uhrich KE
J Control Release; 2014 Jun; 184():28-35. PubMed ID: 24727076
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E
Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532
[TBL] [Abstract][Full Text] [Related]
8. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).
Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T
Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134
[TBL] [Abstract][Full Text] [Related]
9. Co-localization of fluorescent labeled lipid nanoparticles with specifically tagged subcellular compartments by single particle tracking at low nanoparticle to cell ratios.
Tiffany M; Szoka FC
J Drug Target; 2016 Nov; 24(9):857-864. PubMed ID: 27600702
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of vein graft stenosis with a c-jun targeting DNAzyme in a cationic liposomal formulation containing 1,2-dioleoyl-3-trimethylammonium propane (DOTAP)/1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE).
Li Y; Bhindi R; Deng ZJ; Morton SW; Hammond PT; Khachigian LM
Int J Cardiol; 2013 Oct; 168(4):3659-64. PubMed ID: 23886527
[TBL] [Abstract][Full Text] [Related]
11. Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems.
Rezaee M; Oskuee RK; Nassirli H; Malaekeh-Nikouei B
J Control Release; 2016 Aug; 236():1-14. PubMed ID: 27317365
[TBL] [Abstract][Full Text] [Related]
12. Polymeric nanoparticles for siRNA delivery and gene silencing.
Patil Y; Panyam J
Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242
[TBL] [Abstract][Full Text] [Related]
13. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
14. Chitosan-lipid nanoparticles (CS-LNPs): Application to siRNA delivery.
Tezgel Ö; Szarpak-Jankowska A; Arnould A; Auzély-Velty R; Texier I
J Colloid Interface Sci; 2018 Jan; 510():45-56. PubMed ID: 28934610
[TBL] [Abstract][Full Text] [Related]
15. Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA.
Bouxsein NF; McAllister CS; Ewert KK; Samuel CE; Safinya CR
Biochemistry; 2007 Apr; 46(16):4785-92. PubMed ID: 17391006
[TBL] [Abstract][Full Text] [Related]
16. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.
Sakurai Y; Hatakeyama H; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
Biol Pharm Bull; 2009 May; 32(5):928-32. PubMed ID: 19420766
[TBL] [Abstract][Full Text] [Related]
17. Endocytic Transport of Polyplex and Lipoplex siRNA Vectors in HeLa Cells.
Lazebnik M; Keswani RK; Pack DW
Pharm Res; 2016 Dec; 33(12):2999-3011. PubMed ID: 27585903
[TBL] [Abstract][Full Text] [Related]
18. Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin.
Zuidam NJ; Barenholz Y
Biochim Biophys Acta; 1997 Oct; 1329(2):211-22. PubMed ID: 9371413
[TBL] [Abstract][Full Text] [Related]
19. Polyethylenimine as a promising vector for targeted siRNA delivery.
Nimesh S
Curr Clin Pharmacol; 2012 May; 7(2):121-30. PubMed ID: 22432843
[TBL] [Abstract][Full Text] [Related]
20. DOTAP functionalizing single-walled carbon nanotubes as non-viral vectors for efficient intracellular siRNA delivery.
Li H; Hao Y; Wang N; Wang L; Jia S; Wang Y; Yang L; Zhang Y; Zhang Z
Drug Deliv; 2016; 23(3):840-8. PubMed ID: 24892622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]